Emergency contraception and risk for sexually transmitted infections among U.S. women

Journal of Women's Health

Volumn 21, Issue 9, 2012, Pages 910-916

  Habel, Melissa A ^a   Leichliter, Jami S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIACEAE INFECTION; CONDOM; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY CONTRACEPTION; FAMILY PLANNING; FEMALE; HEALTH SERVICE; HUMAN; INFECTION RISK; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADOLESCENT; ADULT; CONDOMS; CONTRACEPTION, POSTCOITAL; COUNSELING; FEMALE; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; ODDS RATIO; REPRODUCTIVE HEALTH SERVICES; RISK; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84865709666     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3441     Document Type: Article

References (31)

1. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. National Center for Health Statistics, Vital Health Statistics, 23, 2010.
2. U. S. Food and Drug Administration. FDA approves overthecounter access for plan B for women 18 and older. August 24, 2006. Available at www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm134289.htm Accessed June 7, 2011.
3. Black KI, Mercer CH, Johnson AM, et al. Sociodemographic and sexual health profile of users of emergency contraception: Data from a British probability sample survey. Contraception 2006;74:309-312.
4. Verhoeven V, Peremans L, Avonts D, et al. The profile of emergency contraception users in a chlamydia prevalence study in primary care in Belgium. Eur J Contracept Reprod Health Care 2006;11:175-180.
5. Bajos N, Leridon H, Goulard H, et al. Contraception: From accessibility to efficiency. Hum Reprod 2003;18:994-999.
6. Kettle H, Cay S, Brown A, et al. Screening for Chlamydia trachomatis infection is indicated for women under 30 using emergency contraception. Contraception 2002;66:251-253.
7. Goulard H, Bajos N, Job-Spira N. Equipe Cocon, emergency contraception in France: The user profile. Gynecol Obstet Fertil 2003;31:724-799.
8. Phipps MG, Matteson KA, Fernandez GE, et al. Characteristics of women who seek emergency contraception and family planning services. Am J Obstet Gynecol 2008;199:111.e1-111.e5.
9. Parrish JW, Katz AR, Grove JS, et al. Characteristics of women who sought emergency contraception at a universitybased women's health clinic. Am J Obstet Gynecol 2009;201:22.e1-7.
10. Sander PM, Raymond EG, Weaver MA. Emergency contraceptive use as a marker of future risky sex, pregnancy and sexually transmitted infection. Am J Obstet Gynecol 2009;201:146.e1-146.e6.
11. Stewart HE, Gold MA, Parker AM. The impact of using emergency contraception on reproductive health outcomes: A retrospective review in an urban adolescent clinic. J Pediatr Adolesc Gynecol 2003;16:313-318.
12. Kavanaugh ML, Williams SL, Schwarz EB. Emergency contraception use and counseling after changes in United States prescription status. Fertil Steril 2011;30:95:2578-2581.
13. Kaiser Family Foundation. Emergency contraception. Women's Health Policy Facts 2005. Available at www.kff.org/womenshealth/upload/3344-03.pdf Accessed June 7, 2011.
14. Groves RM, Mosher WD, Lepkowski J, et al. Planning and development of the continuous National Survey of Family Growth, National Center for Health Statistics. Vital Health Stat 2009. Available at www.cdc.gov/nchs/data/series/ sr-01/sr01-048.pdf
15. Lepkowski JM, Mosher, WD, Davis KE, et al. The 2006-2010 National Survey of Family Growth: Sample design and analysis of a continuous survey, National Center for Health Statistics. Vital Health Stat 2010. Available at www.cdc.gov/nchs/data/series/sr-02/sr02-150.pdf
16. Meyer J, Gold M, Haggerty C, et al. Advance provision of emergency contraception among adolescent and young adult women: A systematic review of literature. J Pediatr Adolesc Gynecol 2011;24:2-9.
17. Polis CB, Schaffer K, Blanchard K, et al. Advance provision of emergency contraception for pregnancy prevention: A meta-analysis. Obstet Gynecol 2007;110:1379-1388.
18. De Navas-Walt C, Proctor BD, Smith JC. U. S. Census Bureau current population reports, P60-238. Income, poverty, and health insurance coverage in the United States: 2009. Washington, DC: U. S. Government Printing Office, 2010.
19. Whittaker PG, Berger M, Armstrong KA, et al. Characteristics associated with emergency contraception use by family planning patients: A prospective cohort study. Perspect Sex Reprod Health 2007;39:158-166.
20. Raine TR, Harper C, Leon K, Darney P. Emergency contraception: Advance provision in a young, high-risk clinic population. Obstet Gynecol 2000;96:1-7.
21. Jackson RA, Schwarz EB, Freedman L, Darney P. Advance supply of emergency contraception: Effects on use and usual contraception-A randomized trial. Obstet Gynecol 2003;102:8-16.
22. Raine TR, Harper CC, Rocca CH, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: A randomized controlled trial. JAMA 2005;293:54-62.
23. Walsh TL, Frezieres RG. Patterns of emergency contraception use by age and ethnicity from a randomized trial comparing advance provision and information only. Contraception 2006;74:110-117.
24. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(No. RR-12):1-114.
25. Raymond EG, Stewart F, Weaver M, et al. Impact of increased access to emergency contraceptive pills: A raondomized controlled trial. Obstet Gynecol 2006;108:1098-1106.
26. Baraister P, Pearce V, Holmes J, et al. Chlamydia testing in community pharmacies: Evaluation of a feasibility pilot in south east London. Qual Saf Health Care 2007;16:303-307.
27. Healthcare TN. Pharmacy Chlamydia Screening Pathfinder Evaluation (PCSPF) final. London: Department of Health, 2007.
28. Anderson C, Thornley T. A pharmacy-based private chlamydia screening programme: Results from the first 2 years of screening and treatment. Int J Clin Pharm 2001;33:88-91.
29. Habel M, Scheinmann R, Verdesoto E, et al. Behind-thecounter emergency contraception: Exploring chlamydia and gonorrhea testing in the pharmacy setting. National STD Prevention Conference, March 2012, Minneapolis, MN.
30. Calderon Y, Cowan E, Molano F, et al. Assessing HIV testing in community pharmacies as a complementary community site to an HIV testing and counseling program based in a New York City emergency department. Conference on Retroviruses and Opportunistic Infections, 2011, Boston, MA.
31. Amesty S, Weidle PJ, Willis L, Sutton M, Lin S, Fuller C. Support for in-pharmacy HIV testing and prevention services among pharmacists registered in the New York State Expanded Syringe Access Program: Findings from the PHARM-HIV study. American Pharmacists Association Annual Meeting and Exposition, March 2012, New Orleans, LA.